These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 24764317)

  • 1. Enhanced anticancer efficacy by ATP-mediated liposomal drug delivery.
    Mo R; Jiang T; Gu Z
    Angew Chem Int Ed Engl; 2014 Jun; 53(23):5815-20. PubMed ID: 24764317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Biomolecular Corona of Liposomal Doxorubicin: The Overlooked Factor in Anticancer Drug Delivery.
    Caracciolo G; Palchetti S; Digiacomo L; Chiozzi RZZ; Capriotti AL; Amenitsch H; Tentori PM; Palmieri V; Papi M; Cardarelli F; Pozzi D; Laganà A
    ACS Appl Mater Interfaces; 2018 Jul; 10(27):22951-22962. PubMed ID: 29905462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo.
    Obata Y; Tajima S; Takeoka S
    J Control Release; 2010 Mar; 142(2):267-76. PubMed ID: 19861141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
    Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
    Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous liposome membranes with pH-triggered permeability enhance the in vitro antitumor activity of folate-receptor targeted liposomal doxorubicin.
    Mamasheva E; O'Donnell C; Bandekar A; Sofou S
    Mol Pharm; 2011 Dec; 8(6):2224-32. PubMed ID: 21899300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
    Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system.
    Kakudo T; Chaki S; Futaki S; Nakase I; Akaji K; Kawakami T; Maruyama K; Kamiya H; Harashima H
    Biochemistry; 2004 May; 43(19):5618-28. PubMed ID: 15134436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP-responsive DNA-graphene hybrid nanoaggregates for anticancer drug delivery.
    Mo R; Jiang T; Sun W; Gu Z
    Biomaterials; 2015 May; 50():67-74. PubMed ID: 25736497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.
    Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q
    Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of pH and intraliposomal buffer strength on the rate of liposome content release and intracellular drug delivery.
    Lee RJ; Wang S; Turk MJ; Low PS
    Biosci Rep; 1998 Apr; 18(2):69-78. PubMed ID: 9743475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor efficacy following the intracellular and interstitial release of liposomal doxorubicin.
    Bandekar A; Karve S; Chang MY; Mu Q; Rotolo J; Sofou S
    Biomaterials; 2012 Jun; 33(17):4345-52. PubMed ID: 22429980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery.
    Park JH; Cho HJ; Yoon HY; Yoon IS; Ko SH; Shim JS; Cho JH; Park JH; Kim K; Kwon IC; Kim DD
    J Control Release; 2014 Jan; 174():98-108. PubMed ID: 24280260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome.
    Xiao W; Chen X; Yang L; Mao Y; Wei Y; Chen L
    Int J Pharm; 2010 Jun; 393(1-2):119-26. PubMed ID: 20416367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-triggered anticancer drug delivery.
    Mo R; Jiang T; DiSanto R; Tai W; Gu Z
    Nat Commun; 2014 Mar; 5():3364. PubMed ID: 24618921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pH-responsive, endosomolytic liposome functionalized with membrane-anchoring, comb-like pseudopeptides for enhanced intracellular delivery and cancer treatment.
    Chen S; Morrison G; Liu W; Kaur A; Chen R
    Biomater Sci; 2022 Nov; 10(23):6718-6730. PubMed ID: 36279005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of novel drug delivery system, fusogenic liposome, for cancer therapy].
    Kunisawa J; Mayumi T
    Gan To Kagaku Ryoho; 2001 May; 28(5):577-83. PubMed ID: 11383204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-targeted liposome design: challenges and fundamental considerations.
    Noble GT; Stefanick JF; Ashley JD; Kiziltepe T; Bilgicer B
    Trends Biotechnol; 2014 Jan; 32(1):32-45. PubMed ID: 24210498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular structural transformation regulated dynamic disordering of supramolecular vesicles as pH-responsive drug release systems.
    Liu Y; Gao FP; Zhang D; Fan YS; Chen XG; Wang H
    J Control Release; 2014 Jan; 173():140-7. PubMed ID: 24188958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.